sales@scalarmarketresearch.com  |   +1-800-213-5170  (U.S./ Canada Toll-free)  |  REGISTER |  SIGN IN

Home >> Reports >> vaccines market

report

Vaccines Market, by Mechanism of Action (Monovalent Vaccines, Multivalent Vaccines), Type (Attenuated Vaccines, Inactive Vaccines, Toxoid Vaccines, Conjugated Vaccines), End-user (Pediatrics Vaccines, Adult Vaccines) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC200 Upcoming FREE 10% CUSTOMIZATION

The objective of this report is to describe the market trends and revenue forecasts for the vaccines market for the next five years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the vaccines market. The scope of this report covers the vaccines market by its major segments, which include the mechanism of action, types, end-users, and the major geographic regions.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the market segments that will showcase the greatest growth potential
  • Information about the technological advancements influencing the growth of the global market
  • Extensive analysis of the key players dominating the competitive landscape of this market

KEY PREMIUM INDUSTRY INSIGHTS

  • Increasing prevalence of chronic diseases, increasing government initiatives, participation of the non-governmental organizations in immunization are the key drivers for the vaccines market.
  • WHO and UNICEF have published guidelines for the developing countries that intend to provide equal access to vaccination institutes and to implement feasible financial strategies, which are driving the vaccines market.
  • The consistently increasing global immunization coverage has led to favorable growth of vaccine market.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s vaccines market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the vaccines market by the following segments:

  • Vaccines Market, by Mechanism of Action
    • Monovalent Vaccines
    • Multivalent Vaccines
  • Vaccines Market, by Types
    • Attenuated Vaccines
    • Inactive Vaccines
    • Toxoid Vaccines
    • Conjugated Vaccines
  • Vaccines Market, by End-users
    • Pediatric Vaccines
    • Adult Vaccines

KEY MARKET PLAYERS

Key players in the vaccines market include:

  • Emergent BioSolutions, Inc.
  • Johnson & Johnson
  • Astellas Pharma Inc.
  • CSL Limited
  • GlaxoSmithKline plc.
  • Emergent BioSolutions, Inc.
  • Pfizer, Inc.
  • Merck & Co, Inc.
  • Sanofi Pasteur
  • MedImmune

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K.
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

Vaccines Market

TRENDING RELATED REPORT

Pen Needles Market, by Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Types (Safety Pen Needles, Standard Pen Needles), Applications (Insulin, Growth Hormone, Glucagon-Like-Peptide Therapy 1) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definition
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Patent Analysis
    3. Pricing Analysis
    4. Regulatory Analysis
  5. VACCINES MARKET, BY MECHANISM OF ACTION
    1. Segment Share
    2. By Mechanism of Action
      1. Monovalent Vaccines
      2. Multivalent Vaccines
  6. VACCINES MARKET, BY TYPES
    1. Segment Share
    2. By Types
      1. Attenuated Vaccines
      2. Inactive Vaccines
      3. Toxoid Vaccines
      4. Conjugated Vaccines
  7. VACCINES MARKET, BY END-USERS
    1. Segment Share
    2. By End-Users
      1. Pediatric Vaccines
      2. Adult Vaccines
  8. VACCINES MARKET, BY GEOGRAPHY
    1. North America
      1. By Country
        1. U.S.
        2. Rest of North America
      2. By Mechanism of Action
      3. By End-users
      4. By  Types
    2. Europe
      1. By Country
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Mechanism of Action
      3. By End-users
      4. By  Types
    3. Asia-Pacific
      1. By Country
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Mechanism of Action
      3. By End-users
      4. By  Types
    4. Rest of the World
      1. By Country
        1. Latin America
        2. Middle East & Africa
      2. By Mechanism of Action
      3. By End-users
      4. By  Types
  9. COMPETITIVE LANDSCAPE
    1. Market Share Analysis
    2. Key Innovator Companies
  10. KEY MARKET PLAYERS
    1. Emergent BioSolutions, Inc
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. Johnson & Johnson
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. Astellas Pharma Inc
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. CSL Limited
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5. GlaxoSmithKline plc
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. Emergent BioSolutions, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    7. Pfizer, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    8. Merck & Co., Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    9. Sanofi SA
      1. Overview
      2. Key Strategies
      3. Recent Developments
    10. MedImmune
      1. Overview
      2. Key Strategies
      3. Recent Developments
  11. SCALAR 360 DEGREE MARKET PERSPECTIVE
  12. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170
EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

  • Unparalleled Expertise

    Our industry experts hold inimitable know-how across wide range of industry verticals

  • Assured Quality

    We deliver high-quality, real-time and data-driven industry insights to our clients

  • 24x7 Analyst Support

    We offer pre-purchase and post-purchase support from our industry experts

  • Privacy & Security

    All your personal information and confidential details are safe and secure with us